Percutaneous absorption and metabolism of [14C]-ethoxycoumarin in a pig ear skin model.

The biotransformation of chemicals by the skin can be a critical determinant of systemic exposure in humans following dermal absorption. Pig ear skin, which closely resembles human skin, is a candidate ex vivo alternative model for the investigation of xenobiotics penetration and metabolism. We developed an ex vivo pig ear skin model and explored its absorption, diffusion and metabolic capabilities using the model compound (14)C-ethoxycoumarin (7-EC). Experimentations were undertaken on pig ear skin explants after application of various (14)C-EC doses. Diffusion was quantified as well as the production of 7-EC metabolites resulting from phases I and II enzyme activities, using radio-HPLC. After 48h, most of the radioactivity was absorbed and was recovered in culture media (70%) or in the skin itself (10%). 7-EC metabolites were identified as 7-hydroxycoumarin (OH-C) and the corresponding sulfate (S-O-C) and glucuronide (G-O-C) conjugates. Their formation followed Michaelis-Menten kinetics with saturation reached around 100 microM of 7-EC. Results demonstrate that dermal absorption as well as phases I and II enzymatic activities of pig skin are both functional. This model should represent a valuable alternative for the study of the transdermal exposure to chemicals, combining a functional dermal barrier and active biotransformation capabilities.

Biotransformations of bisphenol A in a mammalian model: answers and new questions raised by low-dose metabolic fate studies in pregnant CD1 mice.

We investigated the metabolic fate of a low dose (25 micro g/kg) of bisphenol A [2,2-bis(4-hydroxy-phenyl)propane] (BPA) injected subcutaneously in CD1 pregnant mice using a tritium-labeled molecule. Analytic methods were developed to allow a radio-chromatographic profiling of BPA residues in excreta and tissues, as well as in mothers' reproductive tracts and fetuses, that contained more than 4% of the administered radioactivity. BPA was extensively metabolized by CD1 mice. Identified metabolite structures included the glucuronic acid conjugate of BPA, several double conjugates, and conjugated methoxylated compounds, demonstrating the formation of potentially reactive intermediates. Fetal radioactivity was associated with unchanged BPA, BPA glucuronide, and a disaccharide conjugate. The latter structure, as well as that of a dehydrated glucuronide conjugate of BPA (a major metabolite isolated from the digestive tract), showed that BPA metabolic routes were far more complex than previously thought. The estrogenicity of the metabolites that were identified but not tested for hormonal activity cannot be ruled out; however, in general, conjugated BPA metabolites have significantly lower potency than that of the parent compound. Thus, these data suggest the parental compound is responsible for the estrogenic effects observed in fetuses exposed to BPA during gestation in this mammalian model.

In vivo metabolic fate of the xeno-estrogen 4-n-nonylphenol in Wistar rats.

The distribution and the metabolic fate of 4-n-nonylphenol were investigated in male and female Wistar rats dosed orally with 1 microg/kg ("low-dose") or 10 mg/kg ("high-dose") labeled 4-n-nonylphenol. Following a 4-day metabolic balance study, neither the distribution pattern nor the residual levels of 4-n-nonylphenol were found to be different between groups, and no unexpected tissue-specific accumulation of 4-n-nonylphenol was detected. Most of the radioactivity was eliminated in urine, and consisted of hydrophilic metabolites very likely resulting from extensive beta-oxidation of the nonyl side chain and from the conjugation of the phenol to sulfate or to glucuronic acid. Traces of ring-hydroxylated nonylphenol were also characterized. Fecal excretion was mainly associated with unchanged 4-n-nonylphenol and with side chain hydroxylated 4-n-nonylphenol. Experiments carried out in pregnant rats exposed to a low-dose of 4-n-nonylphenol from day 3 to day 19 of gestation demonstrated similar metabolic pathways for this xeno-estrogen. Very limited amounts, if any, of non metabolized 4-n-nonylphenol did reach fetuses. The oxidative metabolism of 4-n-nonylphenol leads to the formation of both ring-hydroxylated and side chain hydroxylated metabolites. The latter metabolic pathway may be a major metabolic pathway for branched 4-nonyl-phenols and may be a clue to understand their biological activity.